期刊文献+

出血性大肠杆菌O157:H7 vero细胞毒素抗体的保护性研究

Research on Protection of Antibody of a New Verotoxin Produced by Enterohemorrhagic E. coli O157:H7
下载PDF
导出
摘要 目的:在体外研究vero细胞毒素抗体的保护作用。方法:用从出血性大肠杆菌O157:H7中纯化的一种新的vero细胞毒素来免疫家兔,获得多克隆抗体。用不同剂量抗体,在不同时间段与此vero细胞毒素进行vero细胞毒性试验。结果:高剂量的抗体预先处理过的vero细胞,可以受到抗体保护,毒素的细胞毒作用被抑制。预先用毒素作用vero细胞后,一小时内给予大剂量抗体可以部分抑制毒素的细胞毒作用。结论:本试验提示用抗毒素紧急预防和治疗Vero细胞毒素引起的疾病是可行的。 Objective: To study protection of antibody of vero cytotoxin in vitro. Methods: Immunise rabbit with a new verotoxin purified from EHEC O157:H7 strain, and obtain polyclonal rabbit antisera. We used the different dose of antisera and the vero cytotoxin to do the vero cell assay in different of time. Results: High does antisera-treated vero cells were protected and the effect of the cytotoxin was inhibited. When the toxin was used in advance and the high dose of antisera were supply in an hour, that the antisera could inhibit effect of the cytotoxin partly. Conclusion: This test imply that antitoxin can be used for prevention and cure of disease brought by verocytotoxin.
作者 张瑾 杨正时
出处 《中国医药导刊》 2006年第5期362-364,共3页 Chinese Journal of Medicinal Guide
关键词 出血性大肠杆菌O157:H7 Vero细胞毒素 抗体保护作用 Enterohemorrhagic E. coli O157:H7 verotoxin antibody protection
  • 相关文献

参考文献10

  • 1杨正时.产Vero细胞毒素大肠杆菌及其感染[J].国外医学(流行病学.传染病学分册),1990,17(5):204-207. 被引量:3
  • 2Konowalchuk J. et al. Vero response to a cytotoxin of Escherichia coli.Infect Immun., 1977 ; 18(3);775 - 779
  • 3MacLeod DL. and CL. Gyles. Immunization of pigs with a purified Shiga-like toxin II variant toxoid. Vet Microbiol. ,1991 ;29(3-4);309 - 318
  • 4Gordon VM. et al. An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine. Infect Immun. ,1992 ;60(2);485 - 490
  • 5Su GF. et al. Construction of stable LamB-Shiga toxin B subunit hybrids; analysis of expression in Salmonella typhimurium aroA strains and stimulation of B subunit-specific mucosal and serum antibody responses. Infect Immun. ,1992 ;60(8);3345 - 3359
  • 6Downes FP. et al. Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies.Infect Immun. ,1988; 56(8);1926 - 1933
  • 7Nakao H. et al. Monoclonal antibody to Shiga toxin 2 which blocks receptor binding and neutralizes cytotoxicity. Infect Immun. ,1999;67(11);5717 - 5722
  • 8Paton JC.and Paton AW. Pathogenesis and diagnosis of Shiga toxinproducing Escherichia coli infections. Clin Microbiol Rev. ,1998 ;11(3);450 - 479. Review
  • 9Isoqai E. et al. Effect of antibiotics, levofloxacin and fosfomycin, on a mouse model with Escherichia coli O157 infection. Microbiol Immunol.,2000;44(2);89 - 95
  • 10Acheson DW. et al. Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR. Infect Immun. ,1996;64(1);355 - 357

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部